Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects

A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease

NCT00000696 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

NCT00001112 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00005120 ·Status: UNKNOWN ·Phase: PHASE1

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

NCT00594880 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

NCT00078442 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

NCT00002449 ·Status: UNKNOWN ·Phase: PHASE1

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

NCT00000761 ·Status: COMPLETED ·Phase: PHASE1

Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection

NCT00050284 ·Status: COMPLETED

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

NCT00000820 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

NCT00113282 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

NCT00672191 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

NCT00120185 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

NCT00002359 ·Status: COMPLETED ·Phase: PHASE3

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy

NCT00004978 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

NCT00110578 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002004 ·Status: COMPLETED ·Phase: PHASE1

Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

NCT05115838 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

NCT00000779 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers

NCT04672083 ·Status: COMPLETED ·Phase: PHASE1

Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients

NCT00000821 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

NCT00005001 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

NCT00000713 ·Status: COMPLETED ·Phase: PHASE1

A Study of Anti-HIV Monoclonal Antibody KD-247

NCT00917813 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of IL-7 in HIV-infected Patients (Inspire)

NCT00477321 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002005 ·Status: COMPLETED ·Phase: NA